Skip to content
MedsAcross

Alternatives

Alternatives to Bosulif 400 mg tablet

1 other presentations of Bosutinib 400 mg tablet

There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Bosutinib), strength (400 mg) and dosage form (tablet) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.

Side by side

The first row is the medicine you came from.

MedicineManufacturerRegisterPacksStorageLead timeDocumentsAvailability
Bosulif 400 mg tabletThis pageOralPfizer LaboratoriesUS FDA30 tabletsStore at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Storage Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F) and Store and Dispense in Original Container.On request—Available on request
Bosutinib 400 mg tabletOral—US FDA30 tabletsStore at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).On request—Available on request

Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Back to Bosulif 400 mg tablet

Not sure which maker to choose?

Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.